TDF and Entekavir - Hepatitis B Reactivation

Viral Hepatitis Society

Status: Enrolling

Conditions: Hepatitis B Reactivation

Study type: Observational

Funder types: Other

Identifiers

NCT06049602

IMMUNHEP

Details and patient eligibility

About

This is a non-interventional retrospective multi-center study for the patients received Entekavir or TDF for Hepatitis B prophylaxis.

Enrollment: 10,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients used entekavir or TDF for Hepatitis B prophylaxis

Exclusion criteria

• Patients lower then 18 years old.